Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Targeted Therapy Combined With Immunotherapy”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Testing effectiveness (Phase 2)Looking for participantsNCT06521866
What this trial is testing

Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal CarcinomaImmunotherapy
Fudan University 208
Testing effectiveness (Phase 2)UnknownNCT04586088
What this trial is testing

Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more
Sun Yat-sen University 58
Testing effectiveness (Phase 2)Looking for participantsNCT06301399
What this trial is testing

Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study

Who this might be right for
Advanced Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07630363
What this trial is testing

PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC

Who this might be right for
Advanced Renal Cell Carcinoma (RCC)PTCAtorvastatin+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)UnknownNCT04191889
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Who this might be right for
C-staged Hepatocellular Carcinoma in BCLC Classification
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Looking for participantsNCT07138547
What this trial is testing

GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma

Who this might be right for
Lymphoma
Chinese PLA General Hospital 40
Not applicableUnknownNCT05816642
What this trial is testing

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
RenJi Hospital 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03235245
What this trial is testing

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

Who this might be right for
Unresectable Stage III MelanomaStage IV Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 271
Testing effectiveness (Phase 2)Looking for participantsNCT06176885
What this trial is testing

Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
yue junhan 36
Testing effectiveness (Phase 2)Looking for participantsNCT07334483
What this trial is testing

Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC

Who this might be right for
HCC
GrandPharma (China) Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT05628038
What this trial is testing

The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer

Who this might be right for
Recurrent Rectal Cancer
Fudan University 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT07635290
What this trial is testing

Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

Who this might be right for
Previously Treated, AdvancedBiliary Tract Cancers
West China Hospital 26
Testing effectiveness (Phase 2)Looking for participantsNCT06261125
What this trial is testing

Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)

Who this might be right for
Hepatocellular Carcinoma
Mian XI 60
Testing effectiveness (Phase 2)UnknownNCT05549466
What this trial is testing

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 84
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06554535
What this trial is testing

Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung CancerTreatment-naïve for Systemic Therapy Targeting Extensive-Stage Small Cell Lung CancerECOG Performance Status Score of 0 or 1+1 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not applicableUnknownNCT05510466
What this trial is testing

Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in Patients With BRAF Mutated Melanoma With Central Nervous System Metastasis

Who this might be right for
Metastatic Melanoma
University Hospital, Montpellier 18
Testing effectiveness (Phase 2)Looking for participantsNCT07793695
What this trial is testing

Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Anhui Provincial Hospital 60
Testing effectiveness (Phase 2)UnknownNCT06322095
What this trial is testing

GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Patients With Advanced Solid TumorAdvanced Solid Tumor With Oncogenic Driver Mutations
Suzhou Genhouse Bio Co., Ltd. 72
Not applicableStudy completedNCT05535998
What this trial is testing

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma
Yunfei Yuan 743
Not applicableUnknownNCT05215665
What this trial is testing

GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 146
Next Page
43